Psychological effects of ketamine in healthy volunteers. Phenomenological study.

Benito Menni CASM, Barcelona, Spain.
The British Journal of Psychiatry (Impact Factor: 6.61). 09/2006; 189:173-9. DOI: 10.1192/bjp.bp.105.015263
Source: PubMed

ABSTRACT The psychosis-inducing effect of ketamine is important evidence supporting the glutamate hypothesis of schizophrenia. However, the symptoms the drug produces have not been described systematically.
To examine the effects of ketamine in healthy people using a structured psychiatric interview.
Ketamine (200 ng/ml) or placebo was administered by continuous infusion to 15 healthy volunteers. Symptoms were rated using the Present State Examination, the Thought, Language and Communication Scale and the Scale for Assessment of Negative Symptoms.
Ketamine induced a range of perceptual distortions, but not hallucinations. Referential ideas were seen in nearly half the sample. There were only mild and infrequent ratings on the thought disorder scale. Affective flattening and alogia were seen in some volunteers.
Ketamine does not reproduce the full picture of schizophrenia. The main point of similarity concerns referential thinking. Phenomena resembling negative symptoms are also seen, but the distinction of these from the drug's sedative effects requires further elucidation.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A considerable number of recent experimental and computational studies suggest that subtle impairments of excitatory-to-inhibitory (E/I) balance or regulation are involved in many neurological and psychiatric conditions. The current paper aims at specifically and quantitatively relating E/I imbalance with psychotic symptoms in schizophrenia. Considering that the brain constructs hierarchical causal models of the external world, we show that the failure to maintain the E/I balance results in hallucinations as well as in the formation and subsequent consolidation of delusional beliefs. Indeed, the consequence of E/I imbalance in a hierarchical neural network is equated to a pathological form of causal inference called "Circular Belief Propagation". In circular belief propagation, bottom-up sensory information and top-down predictions are reverberated, i.e., prior beliefs are misinterpreted as sensory observations and vice versa. As a result, these predictions are counted multiple times. Circular inference explains the emergence of erroneous percepts, the patient’s overconfidence when facing probabilistic choices, the learning of “unshakable” causal relationships between unrelated events and a paradoxical immunity to perceptual illusions, which are all known to be associated with schizophrenia.
    Brain 09/2013; 136(11):3227-3241. · 9.92 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Indirect evidence supporting the organic underpinnings of mental illness has accumulated over the past five decades, driven by advances in neuropharmacology, neurochemistry, neuroimaging, and neuropathology, and by expanding knowledge of the structural and ultra-structural changes that occur within the brains of patients with behavioural and affective symptoms. 1 Yet, despite a growing body of evidence, a distinction continues to be drawn between psychological anomalies of the mind and organic disorders of the nervous system. The recent isolation and characterization of pathogenic autoantibodies within the blood and cerebrospinal fluid of patients with symptoms and signs commonly associated with 'mental illness' raises new questions about the origins and pathogenesis of behavioural and affective disorders, providing a timely and welcome challenge to the ideology that divides mental illness and neurological disorders. „ Autoimmune synaptic protein encephalopathy syndromes and the interplay between mental health, neurology and immunology
    Health Science Inquiry. 06/2013; 4(1):89-92.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: When drug-induced psychoses were first identified in the mid-20th century, schizophrenia was considered a discrete disease with a likely genetic cause. Consequently, drug-induced psychoses were not considered central to understanding schizophrenia as they were thought to be phenocopies rather than examples of the illness secondary to a particular known cause. However, now that we know that schizophrenia is a clinical syndrome with multiple component causes, then it is clear that the drug-induced psychoses have much to teach us. This article shows how the major neuropharmacological theories of schizophrenia have their origins in studies of the effects of drugs of abuse. Research into the effects of LSD initiated the serotonergic model; amphetamines the dopamine hypothesis, PCP and ketamine the glutamatergic hypothesis, while most recently the effects of cannabis have provoked interest in the role of endocannabinoids in schizophrenia. None of these models account for the complete picture of schizophrenia; rather the various drug models mimic different aspects of the illness. Determining the different molecular effects of those drugs whose pharmacological effects do and do not mimic the various aspects of schizophrenia has much to teach us concerning the pathogenesis of the illness. © 2013 Wiley Periodicals, Inc.
    American Journal of Medical Genetics Part B Neuropsychiatric Genetics 10/2013; 162(7):661-70. · 3.23 Impact Factor


1 Download